Pompe Disease in Emerging Markets: Progress and Possibilities Pompe disease is a rare, progressive genetic condition caused by a deficiency of the enzyme acid alpha-glucosidase (GAA). This deficiency leads to the buildup of glycogen in muscles and tissues, causing severe muscle weakness and respiratory problems that significantly affect a patien
Decade of Dominance: Who Will Lead the Multiple Myeloma Treatment Revolution? The Battle for Supremacy in the Multiple Myeloma Treatment Market: BMS vs. Janssen The competition between pharmaceutical titans Bristol Myers Squibb (BMS) and Janssen is intensifying in the Multiple Myeloma treatment market. Both companies have introduced groundbreakin
Shaping Tomorrow’s Cancer Therapies at AACR 2025 AACR 2025: Shaping the Future of Cancer Research What is AACR? The American Association for Cancer Research (AACR) is a globally recognized organization dedicated to advancing cancer research. Established in 1907, AACR serves as a key platform for researchers, clinicians, and healthcare professi